| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |